Cargando…

Targeting Melanin in Melanoma with Radionuclide Therapy

Nearly 100,000 individuals are expected to be diagnosed with melanoma in the United States in 2022. Treatment options for late-stage metastatic disease up until the 2010s were few and offered only slight improvement to the overall survival. The introduction of B-RAF inhibitors and anti-CTLA4 and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Kevin J. H., Malo, Mackenzie E., Jiao, Rubin, Dadachova, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455397/
https://www.ncbi.nlm.nih.gov/pubmed/36076924
http://dx.doi.org/10.3390/ijms23179520